Heinz-Josef Lenz, MD
University of Southern California
13
4
5
N/A
0
14
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+19 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Syma Iqbal, MD
University of Southern California
Shared therapeutic areas:
Worked with same sponsors:
Robert P. Whitehead, MD
University of Texas
Shared therapeutic areas:
Worked with same sponsors:
James L. Abbruzzese, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Morton S. Kahlenberg, MD
The University of Texas Health Science Center at San Antonio
Shared therapeutic areas:
Worked with same sponsors:
Charles R. Thomas, MD
The University of Texas Health Science Center at San Antonio
Shared therapeutic areas:
Worked with same sponsors:
Stephen R. Smalley, MD
Radiation Oncology Center of Olathe
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Aminah Jatoi, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Ajay Goel, PhD
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19
Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer
Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum
Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
All 13 trials loaded